Patent · US Active

Reagents for treatment of hepatitis B virus (HBV) infection and use thereof

US11535851B2 · kind B2 · utility

0Cited by
1References
23Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 5, 2017
Grant dateDec 27, 2022
Priority date—
Expiry dateSep 15, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2330/51
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This disclosure relates to RNA interference (RNAi) reagents for treatment of hepatitis B virus (HBV) infection, compositions comprising same, and use thereof to treat individuals infected with HBV. The reagents are artificial miRNA (shmiRNA) used alone or in combination with additional shmiRNA or shRNA.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.